Quantcast
Channel: Medical Xpress - spotlight medical and health news stories
Viewing all articles
Browse latest Browse all 12727

'Undruggable' mutation meets its match: Six-year effort yields first drug to target important cancer gene

$
0
0
In the field of drug design, the protein K-Ras is legendary. It's been on everyone's "target" list for more than 30 years due to its status as the most commonly mutated oncogene in human cancers. Despite this high profile, K-Ras has earned a reputation in scientific circles as being "undruggable" because many pharmaceutical, biotech, and academic laboratories have failed to design a drug that successfully targets the mutant gene.

Viewing all articles
Browse latest Browse all 12727

Trending Articles



<script src="https://jsc.adskeeper.com/r/s/rssing.com.1596347.js" async> </script>